Literature DB >> 7672823

Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene.

C De Smet1, S J Courtois, I Faraoni, C Lurquin, J P Szikora, O De Backer, T Boon.   

Abstract

The MAGE1 gene codes for an antigen recognized on melanoma cell line MZ2-MEL by autologous cytolytic T lymphocytes. It is expressed in a number of tumors of different histological origins, but not in normal tissues except in testis. The MAGE1 promoter region was analyzed by performing transient transfections in MZ2-MEL cells with luciferase reporter plasmids. A fragment extending from nucleotide -792 to +118 exhibited high transcriptional activity. By deletional analysis of this fragment, we identified five activating regions designated C, A, B', B, and D. The activity of region A depends on the presence of region B' and vice versa. Two inverted Ets motifs contained in regions B' and B were found to drive 90% of the activity of the MAGE1 promoter in MZ2-MEL cells. Electrophoretic mobility shift assays performed with a nuclear extract from MZ2-MEL cells and with competitor oligonucleotides containing an Ets consensus site showed that nuclear proteins bind to the Ets motif of regions B' and B. Similar experiments suggested that region A binds transcription factors of the Sp1 family. The MAGE1 promoter was found to exert transcriptional activity in tumor cells where the MAGE1 gene is not expressed, suggesting that other mechanisms, such as demethylation, may contribute to the tumor-specific expression of the gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672823     DOI: 10.1007/bf00176446

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  32 in total

1.  Evidence that the upstream stimulatory factor and the Sp1 transcription factor bind in vitro to the promoter of the human-growth-hormone gene.

Authors:  F P Lemaigre; S J Courtois; D A Lafontaine; G G Rousseau
Journal:  Eur J Biochem       Date:  1989-05-15

2.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

3.  A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor.

Authors:  E H Postel; S E Mango; S J Flint
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

4.  Luciferase reporter gene vectors for analysis of promoters and enhancers.

Authors:  S K Nordeen
Journal:  Biotechniques       Date:  1988-05       Impact factor: 1.993

5.  An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter.

Authors:  R W Carthew; L A Chodosh; P A Sharp
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

6.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

7.  Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat.

Authors:  Y R Boisclair; A L Brown; S Casola; M M Rechler
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

8.  Production of stable cytolytic T-cell clones directed against autologous human melanoma.

Authors:  M Hérin; C Lemoine; P Weynants; F Vessière; A Van Pel; A Knuth; R Devos; T Boon
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

9.  Presence on a human melanoma of multiple antigens recognized by autologous CTL.

Authors:  B Van den Eynde; P Hainaut; M Hérin; A Knuth; C Lemoine; P Weynants; P van der Bruggen; R Fauchet; T Boon
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

10.  Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1.

Authors:  A Gégonne; R Bosselut; R A Bailly; J Ghysdael
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  25 in total

Review 1.  All in the head: obstacles for immune rejection of brain tumours.

Authors:  Paul R Walker; Thomas Calzascia; Pierre-Yves Dietrich
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

2.  The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

Authors:  C De Smet; O De Backer; I Faraoni; C Lurquin; F Brasseur; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Expression of MAGE-A1 mRNA is associated with gene hypomethylation in hepatocarcinoma cell lines.

Authors:  Jiang Xiao; Hong-Song Chen; Ran Fei; Xu Cong; Li-ping Wang; Yan Wang; Dong Jiang; Lai Wei; Yu Wang
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

4.  EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.

Authors:  Zachary R Gallegos; Patrick Taus; Zane A Gibbs; Kathleen McGlynn; Nicholas C Gomez; Ian Davis; Angelique W Whitehurst
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

5.  MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases.

Authors:  Jennifer M Doyle; Jinlan Gao; Jiawei Wang; Maojun Yang; Patrick Ryan Potts
Journal:  Mol Cell       Date:  2010-09-24       Impact factor: 17.970

6.  The biology of cancer testis antigens: putative function, regulation and therapeutic potential.

Authors:  Elisabetta Fratta; Sandra Coral; Alessia Covre; Giulia Parisi; Francesca Colizzi; Riccardo Danielli; Hugues Jean Marie Nicolay; Luca Sigalotti; Michele Maio
Journal:  Mol Oncol       Date:  2011-02-18       Impact factor: 6.603

Review 7.  Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.

Authors:  Stacey N Akers; Kunle Odunsi; Adam R Karpf
Journal:  Future Oncol       Date:  2010-05       Impact factor: 3.404

8.  Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells.

Authors:  Charles De Smet; Axelle Loriot; Thierry Boon
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 9.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

10.  Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer.

Authors:  Anna Woloszynska-Read; Paulette Mhawech-Fauceglia; Jihnhee Yu; Kunle Odunsi; Adam R Karpf
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.